Search Results 91-100 of 16475 for monoclonal antibody

  1. A Study to Evaluate Maximizing Anti-PD-1 Therapy By Monitoring T Cell Responses In Melanoma, Lung and Other Cancer Types - Mayo Clinic

    ... monoclonal antibody, and compare them with clinical outcomes. Participation eligibility. Participant eligibility includes age, gender, type and stage of ...

  2. Waldenstrom Macroglobulinemia Clinical Trials

    Rituximab is a monoclonal antibody that may interfere with the ability of cancer cells to grow and spread. ... Monoclonal antibodies, such as rituximab, can block ...

  3. Multiple myeloma - Symptoms and causes - Mayo Clinic

    The myeloma cells continue trying to make antibodies, as healthy plasma cells do. But the body can't use these antibodies, called monoclonal proteins or M ...

  4. Eculizumab-aeeb (intravenous route) - Mayo Clinic

    Eculizumab-aeeb injection is a monoclonal antibody that works on the immune system. This medicine is available only under a restricted distribution program ...

  5. Clazakizumab for the Treatment of Chronic Active Antibody Mediated Rejection in Kidney Transplant Recipients (IMAGINE) - Mayo Clinic

    About this study. The purpose of this study is to investigate whether clazakizumab (an anti-interleukin (IL)-6 monoclonal antibody (mAb)) may be beneficial ...

  6. A Study to Evaluate Acalabrutinib With or Without Obinutuzumab to Treat Early-Stage Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma Patients - Mayo Clinic

    Acalabrutinib may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. Monoclonal antibodies, such as obinutuzumab, may ...

  7. Cancer to COVID-19: Experimental treatment pivots in record time - Mayo Clinic News Network

    But then the pandemic started. Literature Lightbulb. Lenzilumab is a monoclonal antibody drug. Read more about monoclonal antibodies in, "Monoclonal Antibodies: ...

  8. OCEAN (depemOkimab effiCacy Eosinophilic grAnulomatosis with polyaNgiitis) - Mayo Clinic

    Depemokimab is a humanised, affinity matured monoclonal antibody that blocks human interleukin-5 (IL-5) binding to its receptor. Depemokimab is being ...

  9. Brentuximab Vedotin and Nivolumab With or Without Ipilimumab in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma - Mayo Clinic

    Brentuximab vedotin is a combining monoclonal antibody with an anticancer drug that binds to a protein on the surface of lymphoma cells called cluster of ...

  10. Mayo Clinic research finds immune system responds to mRNA treatment for cancer

    Dong and his team produced an immune system protein in the lab ― a monoclonal antibody ― that can detect the protein levels in tumor tissues. The goal was ...